Innoviva
INVA
134 hedge funds and large institutions have $957M invested in Innoviva in 2016 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 10 closing their positions.
180% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 10
16% more funds holding
Funds holding: 116 → 134 (+18)
14% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 42
20% less capital invested
Capital invested by funds: $1.19B → $957M (-$235M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
96% less call options, than puts
Call options by funds: $943K | Put options by funds: $21.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
+$7.96M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$7M |
| 3 |
Goldman Sachs
New York
|
+$6.11M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$5.25M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$4.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
-$26.1M |
| 2 |
CPM
Chesapeake Partners Management
Baltimore,
Maryland
|
-$20.6M |
| 3 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$16.4M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$16M |
| 5 |
Bank of New York Mellon
New York
|
-$13.6M |
INVA Hedge Fund Activity: Q2 2016 in Review
134 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q2 2016, worth a combined $957M — down 20% from $1.19B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new INVA positions and 10 closed out — a net gain of 18 holders — while 48 added to existing stakes and 42 trimmed.
The largest buyer was Nomura Holdings, adding an estimated $7.96M. The largest seller was Baupost Group, cutting an estimated $26.1M.
- 134 institutional investors held Innoviva (INVA) as of Q2 2016, up from 116 in Q1 2016.
- Funds reported $957M of Innoviva stock for Q2 2016, down 20% quarter-over-quarter.
- 28 funds opened new Innoviva positions in Q2 2016 and 10 closed out, a net change of +18 holders.
- The largest Innoviva buyer in Q2 2016 was Nomura Holdings, an estimated $7.96M added.
- The largest Innoviva seller in Q2 2016 was Baupost Group, an estimated $26.1M sold.
Based on aggregated 13F filings for Q2 2016.